Endogenous adenosine protects preconditioned heart during early minutes of reperfusion by activating Akt
Open Access
- 1 January 2006
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 290 (1) , H441-H449
- https://doi.org/10.1152/ajpheart.00589.2005
Abstract
Ischemic preconditioning (IPC) is thought to protect by activating survival kinases during reperfusion. We tested whether binding of adenosine receptors is also required during reperfusion and, if so, how long these receptors must be populated. Isolated rabbit hearts were subjected to 30 min of regional ischemia and 2 h of reperfusion. IPC reduced infarct size from 32.1 ± 4.6% of the risk zone in control hearts to 7.3 ± 3.6%. IPC protection was blocked by a 20-min pulse of the nonselective adenosine receptor blocker 8-( p-sulfophenyl)-theophylline when started either 5 min before or 10 min after the onset of reperfusion but not when started after 30 min of reperfusion. Protection was also blocked by either 8-cyclopentyl-1,3-dipropylxanthine, an adenosine A1-selective receptor antagonist, or MRS1754, an A2B-selective antagonist, but not by 8-(3-chlorostyryl)caffeine, an A2A-selective antagonist. Blockade of phosphatidylinositol 3-OH kinase (PI3K) with a 20-min pulse of wortmannin also aborted protection when started either 5 min before or 10 or 30 min after the onset of reperfusion but failed when started after 60 min of reflow. U-0126, an antagonist of MEK1/2 and therefore of ERK1/2, blocked protection when started 5 min before reperfusion but not when started after only 10 min of reperfusion. These studies reveal that A1 and/or A2B receptors initiate the protective signal transduction cascade during reperfusion. Although PI3K activity must continue long into the reperfusion phase, adenosine receptor occupancy is no longer needed by 30 min of reperfusion, and ERK activity is only required in the first few minutes of reperfusion.Keywords
This publication has 28 references indexed in Scilit:
- Activation of protein kinase B by adenosine A and A receptors in newborn rat cardiomyocytesJournal of Molecular and Cellular Cardiology, 2004
- Cross-talk between the survival kinases during early reperfusion: its contribution to ischemic preconditioningCardiovascular Research, 2004
- NECA and bradykinin at reperfusion reduce infarction in rabbit hearts by signaling through PI3K, ERK, and NOJournal of Molecular and Cellular Cardiology, 2004
- Timing and Duration of Administration Are Crucial for Antiinfarct Effect of AMP 579 Infused at Reperfusion in Rabbit HeartHeart Disease, 2003
- Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOSJournal of Molecular and Cellular Cardiology, 2003
- Cardioprotective Effects of Transforming Growth Factor-β1 During Early Reoxygenation or Reperfusion Are Mediated by p42/p44 MAPKJournal of Cardiovascular Pharmacology, 2001
- Limitation of Infarct Size in Rabbit Hearts by the Novel Adenosine Receptor Agonist AMP 579 Administered at ReperfusionJournal of Molecular and Cellular Cardiology, 2000
- Role of Protein Kinase C-α in Activation of Ecto-5′-nucleotidase in the Preconditioned Canine MyocardiumBiochemical and Biophysical Research Communications, 1997
- Attenuated Purine Production During Subsequent Ischemia in Preconditioned Rabbit Myocardium is Unrelated to the Mechanism of ProtectionJournal of Molecular and Cellular Cardiology, 1996
- Adenosine receptor‐induced cAMP changes in D384 astrocytoma cells and the effect of bradykinin thereonActa Physiologica Scandinavica, 1992